Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01236651
Other study ID # dr hegab protocol
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received November 8, 2010
Last updated November 8, 2010
Start date November 2010
Est. completion date September 2011

Study information

Verified date November 2010
Source Ain Shams University
Contact mahmoud mohamed
Phone 0020106981179
Email hegab_2008@yahoo.com
Is FDA regulated No
Health authority Egypt:Ain shams university
Study type Interventional

Clinical Trial Summary

Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae


Description:

Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae

Protocol of Thesis Submitted for partial fulfillment of master degree in Obstetrics & Gynecology

The aim of this work is to compare and to evaluate the efficacy of drotaverine hydrochloride versus meperidine hydrochloride on the duration of the 1st stage of labor.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date September 2011
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria: ? primigravida.

- Singleton pregnancy.

- Term gestation i.e, 38-41 weeks.

- Sure, reliable dates documented by ultrasound in the 1st half of pregnancy.

- Vertex presentation with occipito anterior position.

- Efficient uterine contractions at a rate of at least 3 to 4 contractions every 10 minutes, each contraction lasting for at least 40 seconds.

Exclusion Criteria: ? Abnormal presentation or occipito posterior position.

- Multiple pregnancies.

- Cephalo-pelvic disproportion.

- Cervical surgery in the past or history of cervical injury.

- Patients on antihypertensive therapy.

- Known hypersensitivity to drotaverine or meperidine.

- If any other spasmolytic agent had been used within 48 hours.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Effect of Meperidine or Drotaverine on Effacement and Dilatation of the Cervix During Labor in Full Term Primigravidae

Intervention

Drug:
Meperidine
administer 100mg meperidine i.v during the 1st stage of labor and calculate the duration of this stage of labor
Drotaverine
administer 40mg drotaverine i.v during the 1st stage of labor and calculate the duration of this stage of labor

Locations

Country Name City State
Egypt Mahmoud Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary the duration of the first stage of labor the primary outcome is to evaluate whether meperidine or drotaverine is more effective in shortening the duration of the 1st stage of labor 6 monthes No
Primary effect on the duration of the 1st stage of labor the primary outcome is to evaluate whether meperidine or drotaverine is more effective on the duration of the 1st stage of labor 6 monthes No
Secondary effect on pain 6 monthes No